Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Swimmers Plot

<< Previous

Bullboard Posts

Next >>

Post by Kingpin68on Oct 07, 2024 9:41am

324 Views

Post# 36255874

Swimmers Plot

Am I reading the swimmers plot correctly, that there are 11 patients with long-term data pending that were previously complete response when last assessed. Hopefully this will bump up the numbers for the long-term data assuming they are still complete response and can even get the data collected.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023